Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor‐Associated Musculoskeletal Symptoms in Breast Cancer

Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor‐Associated Musculoskeletal Symptoms in Breast Cancer

ABSTRACT Introduction Aromatase inhibitor (AI) therapy reduces breast cancer recurrence risk. However, some patients stop treatment early because of AI‐associated musculoskeletal symptoms (AIMSS). AIMSS is due in part to systemic inflammation. Cannabidiol (CBD) has anti‐nociceptive and anti‐inflamma...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicole M. G. Fleege, Elise A. Miller, Kelley M. Kidwell, Zeb R. Zacharias, Jon Houtman, Kelly Scheu, Kathleen Kemmer, Kevin F. Boehnke, N. Lynn Henry
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Cancer Medicine
Subjects:
aromatase inhibitor associated musculoskeletal symptoms
breast cancer
cannabidiol
cannabis
clinical trial
endocrine therapy
Online Access:https://doi.org/10.1002/cam4.71117
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.71117

Similar Items